Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| METTLER TOLEDO INTERNATIONAL INC/MTD · Entity 3168 | Director | February 17, 2026 | February 19, 2026 |
| STERIS plcSTE · Entity 3228 | Sr. Vice Pres., CFO | June 04, 2025 | June 06, 2025 |
| TELEFLEX INCTFX · Entity 3798 | Director | May 15, 2026 | May 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
METTLER TOLEDO INTERNATIONAL INC/
Report date February 17, 2026 · Filed February 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 50 |
Reported balance
After 2026-02-17 transaction · row 1
1 source rowRow 1 · 2026-02-17 · Grant · Acquired 50 · Balance 50 |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1,353.24 · Expires 2036-02-17 | Direct | 130 |
Reported balance
After 2026-02-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-02-17 · Grant · Acquired 130 · Balance 130 F1: The options vest annually in two equal installments beginning on the first anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest annually in two equal installments beginning on the first anniversary of the date of grant.
STERIS plc
Report date June 04, 2025 · Filed June 06, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 43,891 |
Reported balance
After 2025-06-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-06-04 · Tax withholding · Disposed 341 · Balance 43,891 F1: 341 shares were withheld from the 1,141 restricted shares that vested on June 4, 2025. These 341 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,141 ordinary shares were awarded to Mr. Tokich on June 4, 2024. These vested shares were valued at the NYSE closing market price on June 4, 2025. F2: As of June 4, 2025, 6,506 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 144 on October 1, 2025; 1,293 on June 1, 2026; 564 on June 2, 2026; 741 on June 3, 2026; 1,141 on June 4, 2026; 741 on June 3, 2027; 1,141 on June 4, 2027 and 741 on June 5, 2028. |
| Ordinary SharesSEC Table I · non-derivative | IndirectSee Footnote Below | 3,592 |
Reported balance
Holding disclosure · report date 2025-06-04 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 3,592 F3: Units representing 3,592 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of June 2, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: 341 shares were withheld from the 1,141 restricted shares that vested on June 4, 2025. These 341 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,141 ordinary shares were awarded to Mr. Tokich on June 4, 2024. These vested shares were valued at the NYSE closing market price on June 4, 2025.
F2: As of June 4, 2025, 6,506 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 144 on October 1, 2025; 1,293 on June 1, 2026; 564 on June 2, 2026; 741 on June 3, 2026; 1,141 on June 4, 2026; 741 on June 3, 2027; 1,141 on June 4, 2027 and 741 on June 5, 2028.
F3: Units representing 3,592 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of June 2, 2025.
TELEFLEX INC
Report date May 15, 2026 · Filed May 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,090 |
Reported balance
After 2026-05-15 transaction · row 1
1 source rowRow 1 · 2026-05-15 · Grant · Acquired 1,090 · Balance 1,090 F1: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests 100% on the one-year anniversary of the grant date; provided, however, if the reporting person does not stand for re-election to the issuer's board of directors (the "Board") at the issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting"). |
| Stock Option / (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $129.71 · Expires 2036-05-15 | Direct | 4,793 |
Reported balance
After 2026-05-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-15 · Grant · Acquired 4,793 · Balance 4,793 F2: Stock Option Award vests 100% on the one-year anniversary of the grant date; provided, however, if the reporting person does not stand for re-election to the Board at the 2027 Annual Meeting, the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the 2026 Annual Meeting. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests 100% on the one-year anniversary of the grant date; provided, however, if the reporting person does not stand for re-election to the issuer's board of directors (the "Board") at the issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting").
F2: Stock Option Award vests 100% on the one-year anniversary of the grant date; provided, however, if the reporting person does not stand for re-election to the Board at the 2027 Annual Meeting, the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the 2026 Annual Meeting.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
STERIS plc
Report date March 28, 2019 · Filed March 28, 2019
Section 16 reporting ended · disclosed 2019-03-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, 10 pence par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 1
1 source rowRow 1 · 2019-03-28 · Disposition to issuer · Disposed 50,458 · Balance 0 F1: 25,940 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 4,000 on October 1, 2019; 4,700 on June 1, 2020; 6,000 on June 1, 2021; and 4,240 on May 31, 2022. F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. |
| Ordinary Shares, 10 pence par valueSEC Table I · non-derivative | IndirectSee Footnote Below. | 0 |
Reported balance
After 2019-03-28 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2019-03-28 · Disposition to issuer · Disposed 3,406 · Balance 0 F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F3: Units representing 3,406 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of March 27, 2019. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.34 · Expires 2023-05-31 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-03-28 · Disposition to issuer · Disposed 22,000 · Balance 0 F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 22,000 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.52 · Expires 2024-05-30 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-03-28 · Disposition to issuer · Disposed 28,000 · Balance 0 F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 28,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $67.98 · Expires 2025-08-10 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-03-28 · Disposition to issuer · Disposed 20,000 · Balance 0 F6: This option will become exercisable as follows: 5,000 on May 28, 2016; 5,000 on May 28, 2017; 5,000 on May 28, 2018 and 5,000 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 20,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $69.72 · Expires 2026-06-01 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-03-28 · Disposition to issuer · Disposed 30,000 · Balance 0 F7: This option becomes exercisable as follows: 7,500 on June 1, 2017; 7,500 on June 1, 2018; 7,500 on June 3, 2019 and 7,500 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 30,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.07 · Expires 2027-05-30 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-03-28 · Disposition to issuer · Disposed 32,000 · Balance 0 F8: This option becomes exercisable as follows: 8,000 on May 30, 2018; 8,000 on May 30, 2019; 8,000 on June 1, 2020 and 8,000 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 32,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.22 · Expires 2028-05-31 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2019-03-28 · Disposition to issuer · Disposed 46,664 · Balance 0 F9: This option becomes exercisable as follows: 11,666 on May 31, 2019; 11,666 on June 1, 2020; 11,666 on June 1, 2021 and 11,666 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 46,664 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
Filing footnotes · ownership attribution and instrument terms
F1: 25,940 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 4,000 on October 1, 2019; 4,700 on June 1, 2020; 6,000 on June 1, 2021; and 4,240 on May 31, 2022.
F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
F3: Units representing 3,406 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of March 27, 2019.
F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 22,000 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 28,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F6: This option will become exercisable as follows: 5,000 on May 28, 2016; 5,000 on May 28, 2017; 5,000 on May 28, 2018 and 5,000 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 20,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F7: This option becomes exercisable as follows: 7,500 on June 1, 2017; 7,500 on June 1, 2018; 7,500 on June 3, 2019 and 7,500 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 30,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F8: This option becomes exercisable as follows: 8,000 on May 30, 2018; 8,000 on May 30, 2019; 8,000 on June 1, 2020 and 8,000 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 32,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F9: This option becomes exercisable as follows: 11,666 on May 31, 2019; 11,666 on June 1, 2020; 11,666 on June 1, 2021 and 11,666 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 46,664 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2026 Filed May 20, 2026 00:57 UTC | TELEFLEX INC TFX · Entity 3798 | GrantStock Option / (Right to Buy) · Derivative | 4,793 | $0.00 Strike: $129.71 | $0.00 |
DisclosureSEC source: 0000096943-26-000056 · wk-form4_1779238649.xml · derivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,793 Underlying: Common Stock · 4,793 shares Expires 2036-05-15 F2 · derivative.exercise_date: Stock Option Award vests 100% on the one-year anniversary of the grant date; provided, however, if the reporting person does not stand for re-election to the Board at the 2027 Annual Meeting, the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the 2026 Annual Meeting. Read SEC document |
| May 15, 2026 Filed May 20, 2026 00:57 UTC | TELEFLEX INC TFX · Entity 3798 | GrantCommon Stock | 1,090 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-26-000056 · wk-form4_1779238649.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,090 F1 · kind: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests 100% on the one-year anniversary of the grant date; provided, however, if the reporting person does not stand for re-election to the issuer's board of directors (the "Board") at the issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting"). Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 16:37 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantStock Option (right to buy) · Derivative | 130 | $0.00 Strike: $1,353.24 | $0.00 |
DisclosureSEC source: 0001037646-26-000015 · form4.xml · derivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130 Underlying: Common Stock, par value $0.01 per share · 130 shares Expires 2036-02-17 F1 · derivative.exercise_date: The options vest annually in two equal installments beginning on the first anniversary of the date of grant. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 16:37 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantCommon Stock, par value $0.01 per share | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001037646-26-000015 · form4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50 Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 20:35 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 341 | $242.10 | $82,556.10 |
DisclosureSEC source: 0001628280-25-030035 · wk-form4_1749242097.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,891 F1 · shares: 341 shares were withheld from the 1,141 restricted shares that vested on June 4, 2025. These 341 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,141 ordinary shares were awarded to Mr. Tokich on June 4, 2024. These vested shares were valued at the NYSE closing market price on June 4, 2025. F2 · balance_after: As of June 4, 2025, 6,506 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 144 on October 1, 2025; 1,293 on June 1, 2026; 564 on June 2, 2026; 741 on June 3, 2026; 1,141 on June 4, 2026; 741 on June 3, 2027; 1,141 on June 4, 2027 and 741 on June 5, 2028. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:37 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 7,908 | $0.00 Strike: $267.66 | $0.00 |
DisclosureSEC source: 0001628280-25-029686 · wk-form4_1749155804.xml · derivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,908 Underlying: Ordinary Shares · 7,908 shares Expires 2035-06-03 F3 · derivative.exercise_date: This option becomes exercisable as follows: 1,977 on June 3, 2026, 1,977 on June 3, 2027, 1,977 on June 5, 2028 and 1,977 on June 4, 2029. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:37 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 2,223 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-029686 · wk-form4_1749155804.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,232 F1 · balance_after: As of June 3, 2025, 7,647 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,141 on June 4, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026; 564 on June 2, 2026; 741 on June 3, 2026; 1,141 on June 4, 2026; 741 on June 3, 2027; 1,141 on June 4, 2027 and 741 on June 5, 2028. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:37 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 169 | $242.08 | $40,911.52 |
DisclosureSEC source: 0001628280-25-029364 · wk-form4_1749069385.xml · nonDerivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,009 F4 · shares: 169 shares were withheld from the 564 restricted shares that vested on June 2, 2025. These 169 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 564 ordinary shares were awarded to Mr. Tokich on June 2, 2022. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 5,424 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,141 on June 4, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026; 564 on June 2, 2026; 1,141 on June 4, 2026 and 1,141 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:37 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 172 | $242.08 | $41,637.76 |
DisclosureSEC source: 0001628280-25-029364 · wk-form4_1749069385.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,178 F3 · shares: 172 shares were withheld from the 573 restricted shares that vested on June 2, 2025. These 172 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 573 ordinary shares were awarded to Mr. Tokich on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 5,424 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,141 on June 4, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026; 564 on June 2, 2026; 1,141 on June 4, 2026 and 1,141 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:37 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 386 | $242.08 | $93,442.88 |
DisclosureSEC source: 0001628280-25-029364 · wk-form4_1749069385.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,350 F1 · shares: 386 shares were withheld from the 1,293 restricted shares that vested on June 2, 2025. These 386 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,293 ordinary shares were awarded to Mr. Tokich on May 31, 2023. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 5,424 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,141 on June 4, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026; 564 on June 2, 2026; 1,141 on June 4, 2026 and 1,141 on June 4, 2027. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:36 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 194 | $235.78 | $45,741.32 |
DisclosureSEC source: 0001628280-24-041929 · wk-form4_1727901368.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,736 F1 · shares: 194 shares were withheld from the 432 restricted shares that vested on October 1, 2024. These 194 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 432 ordinary shares were awarded to Mr. Tokich on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 1, 2024. F2 · balance_after: As of October 1, 2024, 7,854 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,293 on June 2, 2025; 573 on June 2, 2025; 564 on June 2, 2025; 1,141 on June 4, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026; 564 on June 2, 2026; 1,141 on June 4, 2026 and 1,141 on June 4, 2027. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:30 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,213 | $0.00 Strike: $114.22 | $0.00 |
DisclosureSEC source: 0001628280-24-040611 · wk-form4_1726605032.xml · derivative · entry 10 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 20,213 shares Expires 2028-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option to purchase 46,664 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 46,664 ordinary shares for $114.22 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:30 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 427 | $247.08 | $105,503.16 |
DisclosureSEC source: 0001628280-24-040611 · wk-form4_1726605032.xml · nonDerivative · entry 7 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,930 F5 · price: Price reflects a weighted average sale price for multiple transactions ranging from $246.4675 to $247.44 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:30 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 5,985 | $245.79 | $1,471,053.15 |
DisclosureSEC source: 0001628280-24-040611 · wk-form4_1726605032.xml · nonDerivative · entry 6 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,357 F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $245.43 to $246.405 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:30 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 3,485 | $244.55 | $852,256.75 |
DisclosureSEC source: 0001628280-24-040611 · wk-form4_1726605032.xml · nonDerivative · entry 5 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,342 F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $244.14 to $245.105 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:30 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 10,316 | $243.53 | $2,512,255.48 |
DisclosureSEC source: 0001628280-24-040611 · wk-form4_1726605032.xml · nonDerivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,827 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $243.08 to $244.07 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:30 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 20,213 | $114.22 | $2,308,728.86 |
DisclosureSEC source: 0001628280-24-040611 · wk-form4_1726605032.xml · nonDerivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 20:30 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,119 | $0.00 Strike: $114.22 | $0.00 |
DisclosureSEC source: 0001628280-24-040611 · wk-form4_1726605032.xml · derivative · entry 9 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,213 Underlying: Ordinary Shares · 3,119 shares Expires 2028-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option to purchase 46,664 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 46,664 ordinary shares for $114.22 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 20:30 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 3,119 | $248.02 | $773,574.38 |
DisclosureSEC source: 0001628280-24-040611 · wk-form4_1726605032.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,930 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $248.00 to $248.08 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 20:30 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 3,119 | $114.22 | $356,252.18 |
DisclosureSEC source: 0001628280-24-040611 · wk-form4_1726605032.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2024 Filed Sep 12, 2024 20:31 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 23,332 | $0.00 Strike: $114.22 | $0.00 |
DisclosureSEC source: 0001628280-24-040240 · wk-form4_1726173088.xml · derivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,332 Underlying: Ordinary Shares · 23,332 shares Expires 2028-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 46,664 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 46,664 ordinary shares for $114.22 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| September 10, 2024 Filed Sep 12, 2024 20:31 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 23,332 | $247.00 | $5,763,004.00 |
DisclosureSEC source: 0001628280-24-040240 · wk-form4_1726173088.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,930 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $247.00 to $247.31 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · balance_after: As of September 10, 2024, 8,286 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 432 on October 1, 2024; 1,293 on June 2, 2025; 573 on June 2, 2025; 564 on June 2, 2025; 1,141 on June 4, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026; 564 on June 2, 2026; 1,141 on June 4, 2026 and 1,141 on June 4, 2027. Read SEC document |
| September 10, 2024 Filed Sep 12, 2024 20:31 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 23,332 | $114.22 | $2,664,981.04 |
DisclosureSEC source: 0001628280-24-040240 · wk-form4_1726173088.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,262 Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:34 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 21,720 | $0.00 Strike: $251.34 | $0.00 |
DisclosureSEC source: 0001628280-24-027073 · wk-form4_1717706086.xml · derivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,720 Underlying: Ordinary Shares · 21,720 shares Expires 2034-06-04 F3 · derivative.exercise_date: This option becomes exercisable as follows: 5,430 on June 4, 2025; 5,430 on June 4, 2026; 5,430 on June 4, 2027 and 5,430 on June 5, 2028. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:34 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 3,423 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-027073 · wk-form4_1717706086.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,930 F1 · balance_after: As of June 4, 2024, 8,286 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 432 on October 1, 2024; 1,293 on June 2, 2025; 573 on June 2, 2025; 564 on June 2, 2025; 1,141 on June 4, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026; 564 on June 2, 2026; 1,141 on June 4, 2026 and 1,141 on June 4, 2027. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:35 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 506 | $228.37 | $115,555.22 |
DisclosureSEC source: 0001628280-24-026873 · wk-form4_1717619741.xml · nonDerivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,507 F3 · shares: 506 shares were withheld from the 1,128 restricted shares that vested on June 3, 2024. These 506 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,128 ordinary shares were awarded to Mr. Tokich on June 2, 2022. These vested shares were valued at the NYSE closing market price on June 3, 2024. F4 · balance_after: As of June 3, 2024, 4,863 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 432 on October 1, 2024; 1,293 on June 2, 2025; 573 on June 2, 2025; 564 on June 2, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026 and 564 on June 2, 2026. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:35 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 771 | $228.37 | $176,073.27 |
DisclosureSEC source: 0001628280-24-026873 · wk-form4_1717619741.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,013 F2 · shares: 771 shares were withheld from the 1,719 restricted shares that vested on June 3, 2024. These 771 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,719 ordinary shares were awarded to Mr. Tokich on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 3, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:35 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 1,100 | $228.37 | $251,207.00 |
DisclosureSEC source: 0001628280-24-026873 · wk-form4_1717619741.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,784 F1 · shares: 1,100 shares were withheld from the 2,452 restricted shares that vested on June 3, 2024. These 1,100 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,452 ordinary shares were awarded to Mr. Tokich on June 1, 2020. These vested shares were valued at the NYSE closing market price on June 3, 2024. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:38 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 580 | $222.88 | $129,270.40 |
DisclosureSEC source: 0001628280-24-026597 · wk-form4_1717533504.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,884 F1 · shares: 580 shares were withheld from the 1,293 restricted shares that vested on May 31, 2024. These 580 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,293 ordinary shares were awarded to Mr. Tokich on May 31, 2023. These vested shares were valued at the NYSE closing market price on May 31, 2024. F2 · balance_after: As of May 31, 2024, 10,162 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,452 on June 3, 2024; 1,719 on June 3, 2024; 1,128 on June 3, 2024; 432 on October 1, 2024; 1,293 on June 2, 2025; 573 on June 2, 2025; 564 on June 2, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026 and 564 on June 2, 2026. Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:31 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 32,000 | $0.00 Strike: $77.07 | $0.00 |
DisclosureSEC source: 0001628280-24-024086 · wk-form4_1715977869.xml · derivative · entry 7 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 32,000 shares Expires 2027-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option to purchase 32,000 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 32,000 ordinary shares for $77.07 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:31 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 6,180 | $236.22 | $1,459,839.60 |
DisclosureSEC source: 0001628280-24-024086 · wk-form4_1715977869.xml · nonDerivative · entry 5 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,464 F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $236.08 to $236.45 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F5 · balance_after: As of May 15, 2024, 11,455 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,293 on May 31, 2024; 2,452 on June 3, 2024; 1,719 on June 3, 2024; 1,128 on June 3, 2024; 432 on October 1, 2024; 1,293 on June 2, 2025; 573 on June 2, 2025; 564 on June 2, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026 and 564 on June 2, 2026. Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:31 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 17,500 | $235.84 | $4,127,200.00 |
DisclosureSEC source: 0001628280-24-024086 · wk-form4_1715977869.xml · nonDerivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,644 F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $235.07 to $236.06 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:31 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 3,281 | $234.54 | $769,525.74 |
DisclosureSEC source: 0001628280-24-024086 · wk-form4_1715977869.xml · nonDerivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,144 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $234.0450 to $234.9550 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:31 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 5,039 | $233.34 | $1,175,800.26 |
DisclosureSEC source: 0001628280-24-024086 · wk-form4_1715977869.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,425 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $233.02 to $233.97 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:31 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 32,000 | $77.07 | $2,466,240.00 |
DisclosureSEC source: 0001628280-24-024086 · wk-form4_1715977869.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:30 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 26,964 | $0.00 Strike: $219.97 | $0.00 |
DisclosureSEC source: 0001209191-23-033757 · doc4.xml · derivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,964 Underlying: Ordinary Shares · 26,964 shares Expires 2033-05-31 F4 · derivative.exercise_date: This option becomes exercisable as follows: 6,741 on May 31, 2024; 6,741 on June 2, 2025; 6,741 on June 1, 2026 and 6,741 on June 1, 2027. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:30 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 3,879 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-033757 · doc4.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,464 F2 · balance_after: As of May 31, 2023, 11,455 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,293 on May 31, 2024; 2,452 on June 3, 2024; 1,719 on June 3, 2024; 1,128 on June 3, 2024; 432 on October 1, 2024; 1,293 on June 2, 2025; 573 on June 2, 2025; 564 on June 2, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026 and 564 on June 2, 2026. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:30 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 830 | $199.97 | $165,975.10 |
DisclosureSEC source: 0001209191-23-033757 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,585 F1 · shares: 830 shares were withheld from the 2,780 restricted shares that vested on May 31, 2023. These 830 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,780 ordinary shares were awarded to Mr. Tokich on May 31, 2019. These vested shares were valued at the NYSE closing market price on May 31, 2023. F2 · balance_after: As of May 31, 2023, 11,455 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,293 on May 31, 2024; 2,452 on June 3, 2024; 1,719 on June 3, 2024; 1,128 on June 3, 2024; 432 on October 1, 2024; 1,293 on June 2, 2025; 573 on June 2, 2025; 564 on June 2, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026 and 564 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 21:03 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 30,748 | $0.00 Strike: $250.06 | $0.00 |
DisclosureSEC source: 0001209191-22-034191 · doc4.xml · derivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,748 Underlying: Ordinary Shares · 30,748 shares Expires 2032-06-02 F3 · derivative.exercise_date: This option becomes exercisable as follows: 7,687 on June 2, 2023, 7,687 on June 3, 2024, 7,687 on June 2, 2025 and 7,687 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 21:03 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 2,256 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034191 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,415 F1 · shares: As of June 2, 2022, 10,356 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,780 on May 31, 2023; 2,452 on June 3, 2024; 1,719 on June 3, 2024; 1,128 on June 3, 2024; 432 on October 1, 2024; 573 on June 2, 2025; 564 on June 2, 2025; 144 on October 1, 2025 and 564 on June 2, 2026. F1 · balance_after: As of June 2, 2022, 10,356 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,780 on May 31, 2023; 2,452 on June 3, 2024; 1,719 on June 3, 2024; 1,128 on June 3, 2024; 432 on October 1, 2024; 573 on June 2, 2025; 564 on June 2, 2025; 144 on October 1, 2025 and 564 on June 2, 2026. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 23:05 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 1,285 | $228.20 | $293,237.00 |
DisclosureSEC source: 0001209191-22-033703 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,159 F1 · shares: 1,285 shares were withheld from the 4,240 restricted shares that vested on May 31, 2022. These 1,285 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,240 ordinary shares were awarded to Mr. Tokich on May 31, 2018. These vested shares were valued at the NYSE closing market price on May 31, 2022. F2 · balance_after: 8,100 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,780 on May 31, 2023; 2,452 on June 3, 2024; 1,719 on June 3, 2024; 432 on October 1, 2024; 573 on June 2, 2025 and 144 on October 1, 2025. Read SEC document |
| April 07, 2022 Filed Apr 8, 2022 21:00 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 8,000 | $250.00 | $2,000,000.00 |
DisclosureSEC source: 0001209191-22-023866 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,444 F1 · shares: This sale of a total of 8,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 4, 2021. F2 · balance_after: 12,340 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,240 on May 31, 2022; 2,780 on May 31, 2023; 2,452 on June 3, 2024; 1,719 on June 3, 2024; 432 on October 1, 2024; 573 on June 2, 2025 and 144 on October 1, 2025. Read SEC document |
| December 23, 2021 Filed Dec 27, 2021 21:32 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $69.72 | $0.00 |
DisclosureSEC source: 0001209191-21-071260 · doc4.xml · derivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 30,000 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option to purchase 30,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 30,000 Old STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| December 23, 2021 Filed Dec 27, 2021 21:32 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 30,000 | $240.00 | $7,200,000.00 |
DisclosureSEC source: 0001209191-21-071260 · doc4.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,444 F2 · shares: This exercise of stock options and sale of a total of 30,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 4, 2021. F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $240.00 to $240.04 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 12,340 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,240 on May 31, 2022; 2,780 on May 31, 2023; 2,452 on June 3, 2024; 1,719 on June 3, 2024; 432 on October 1, 2024; 573 on June 2, 2025 and 144 on October 1, 2025. Read SEC document |
| December 23, 2021 Filed Dec 27, 2021 21:32 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 30,000 | $69.72 | $2,091,600.00 |
DisclosureSEC source: 0001209191-21-071260 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 12,340 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,240 on May 31, 2022; 2,780 on May 31, 2023; 2,452 on June 3, 2024; 1,719 on June 3, 2024; 432 on October 1, 2024; 573 on June 2, 2025 and 144 on October 1, 2025. Read SEC document |
| October 22, 2021 Filed Oct 25, 2021 20:32 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $67.98 | $0.00 |
DisclosureSEC source: 0001209191-21-061498 · doc4.xml · derivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 20,000 shares Expires 2025-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 20,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 20,000 Old STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| October 22, 2021 Filed Oct 25, 2021 20:32 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 20,000 | $235.00 | $4,700,000.00 |
DisclosureSEC source: 0001209191-21-061498 · doc4.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,444 F2 · shares: This exercise of stock options and sale of a total of 20,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 4, 2021. F1 · balance_after: 12,340 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,240 on May 31, 2022; 2,780 on May 31, 2023; 2,452 on June 3, 2024; 1,719 on June 3, 2024; 432 on October 1, 2024; 573 on June 2, 2025 and 144 on October 1, 2025. Read SEC document |
| October 22, 2021 Filed Oct 25, 2021 20:32 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 20,000 | $67.98 | $1,359,600.00 |
DisclosureSEC source: 0001209191-21-061498 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 12,340 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,240 on May 31, 2022; 2,780 on May 31, 2023; 2,452 on June 3, 2024; 1,719 on June 3, 2024; 432 on October 1, 2024; 573 on June 2, 2025 and 144 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 21:02 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (rigt to buy) · Derivative | 9,460 | $0.00 Strike: $228.36 | $0.00 |
DisclosureSEC source: 0001209191-21-059542 · doc4.xml · derivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,460 Underlying: Ordinary Shares · 9,460 shares Expires 2031-10-01 F4 · derivative.exercise_date: This option becomes exercisable as follows: 2,365 on October 3,2022; 2,365 on October 2, 2023; 2,365 on October 1, 2024 and 2,365 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 21:02 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 576 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059542 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,444 F1 · shares: All 576 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 432 on October 1, 2024 and 144 on October 1, 2025. F2 · balance_after: 12,340 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,240 on May 31, 2022; 2,780 on May 31, 2023; 2,452 on June 3, 2024; 1,719 on June 3, 2024; 432 on October 1, 2024; 573 on June 2, 2025 and 144 on October 1, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.